NCAM1 and T-cell non-Hodgkin lymphoma: The initial biopsy suggested natural killer/T-cell (NK/T-cell) lymphoma; a targeted immunohistochemistry (IHC) panel (CD56 and sustentacular S100 positive, Ki-67 30%-40%, lymphoid/cytotoxic markers negative) established the diagnosis.